US FDA creates new webpage on post-market device studies
This article was originally published in Clinica
The US Food and Drug Administration has launched a new webpage to inform the public about post-approval studies conducted with medical devices. The initiative forms part of the agency's efforts to increase transparency about its processes.
You may also be interested in...
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four guidance documents have been posted on the tracker since its last update.
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.